Glucose intolerance aggravation after doxepin treatment could also be attributable to decreased muscle expression of GLUT4, the enzyme involved in the rate-limiting step in muscle glucose metabolism [11,13]. The gene discussed is SLC2A4; the disease is Glucose intolerance.